Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

CARDIOME PHARMA CORP (COM)
Mes dernières consult.
Most popular
Report
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
11/17/2017 11/20/2017 11/21/2017 11/22/2017 11/23/2017 Date
1.75 1.91 1.95 1.95 1.9 Last
29693 25102 25372 16850 12860 Volume
+2.94% +9.14% +2.09% 0.00% -2.56% Change
Financials ( CAD)
Sales 2017 32,1 M
EBIT 2017 -27,5 M
Net income 2017 -33,9 M
Debt 2017 -
Yield 2017 -
Sales 2018 51,3 M
EBIT 2018 -22,5 M
Net income 2018 -18,6 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 2,05x
Capi. / Sales2018 1,28x
Capitalization 65,9 M
More Financials
Company
Cardiome Pharma Corp. is a pharmaceutical company, which engages in the provision of development and commercialization of medical products.It focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.It offers the Brinavess and... 
Sector
Pharmaceuticals
Calendar
03/28Earnings Release
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
11/20 CARDIOME PHARMA : to Present at the 29th Annual Piper Jaffray Healthcare Confere..
11/14 CARDIOME PHARMA : Reports Third Quarter 2017 Financial Results
11/14 CARDIOME PHARMA CORP : Cardiome Pharma Corp. to Host Earnings Call
11/07 CARDIOME PHARMA : To Hold Third Quarter 2017 Financial Results Conference Call O..
10/30 CARDIOME PHARMA : Announces Commercial Launch of Xydalba(TM) in Three New Europe..
09/12 CARDIOME PHARMA : Announces Agreement with Basilea for Distribution of Zevtera®/..
09/06 CARDIOME PHARMA CORP : Cardiome, Pipeline Offers Opportunities Beyond Brinavess
09/05 CARDIOME PHARMA : to Present at the Rodman & Renshaw 19th Annual Global Investme..
08/30 CARDIOME PHARMA : New Data Presented at European Society of Cardiology Congress ..
08/11 CARDIOME PHARMA CORP : Today's Research Reports on Cardiome Pharma Corp., Microb..
More news
Sector news : Biopharmaceuticals
04:16pDJSHIRE PLC SHIRE PLC : Block Listing Interim Review -2-
04:16pDJSHIRE PLC SHIRE PLC : Block Listing Interim Review
09:31aDJBAYER : Amikacin Inhale Fails to Meet Objectives in Phase 3 Trial
11/23 German chemicals companies should review British ops - trade body
11/23DJGLAXOSMITHKLINE : Files Additional Trelegy Ellipta Application to FDA
More sector news : Biopharmaceuticals
News from SeekingAlpha
11/14 Cardiome Pharma's (CRME) CEO William Hunter on Q3 2017 Results - Earnings Cal..
11/14 Cardiome Pharma misses by $0.02, misses on revenue
11/13 Notable earnings after Tuesday?s close
09/04 3 THINGS IN BIOTECH YOU SHOULD LEARN : September 4, 2017
08/24 3 THINGS IN BIOTECH YOU SHOULD LEARN : August 24, 2017
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Average target price 8,91  CAD
Spread / Average Target 369%
EPS Revisions
Managers
NameTitle
William L. Hunter President, Chief Executive Officer & Director
William James O'Shea Chairman
Sheila M. Grant Chief Operating Officer
Justin A. Renz Chief Financial Officer
Richard M. Glickman Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CARDIOME PHARMA CORP-52.02%52
BIOGEN18.54%65 516
CSL LIMITED45.44%50 303
ALEXION PHARMACEUTICALS-12.06%24 039
GRIFOLS SA32.44%18 662
BIOMARIN PHARMACEUTICAL0.18%14 575